|
|
||||||||
|
|
|||||||||
|
|
Instrumentation & Data Analysis: Data Analysis & ManagementData Analysis & Management Posters |
1 UMR 8165 CNRS, Orsay, France; 2 Institut Jules Bordet, Bruxelles, Belgium
1613
Objectives: In patient monitoring based on FDG PET, the best way to characterize changes in tumor uptake remains to be found. We compared the evolution of various parameters potentially relevant for patient monitoring.
Methods: Seventeen pairs of PET/CT tumor images (GE Discovery LS system) acquired 10 to 12 weeks apart over the course of chemotherapy in lung cancer patients were considered. Four delineation methods (expert delineation, 40% of maximum intensity threshold, a contrast-dependent threshold and a fitting method) gave 4 independent volume (V) and total lesion glycolysis (TLG) estimates. 6 independent SUV estimates were obtained using the maximum SUV, and the mean SUV in the 4 delineated regions and in a fixed-size region. Percent changes in tumor features (
V,
SUV and
TLG) were compared to the clinicians interpretation based on visual assessment and maximum SUV.
Results: Percent changes in tumor features highly varied depending on the estimation method. Considering the 17 image pairs, the average coefficients of variation due to different estimation methods were 35% for
SUV, 80% for
TLG and 138% for
V. The clinician found 9 responding (RT), 2 stable (ST) and 6 progressive tumors (PT).
SUV averaged over the 6 SUV estimation methods was always < 0 for RT and > 0 for ST and PT, except in one case. Averaged
V was > 0 for PT and < 0 for ST.
TLG alone could not differentiate between RT, PT and ST, suggesting that joint analysis of
V and
SUV gave more information than
TLG analysis.
Conclusions: When characterizing tumor changes,
SUV was the most reproducible parameter as a function of the estimation method. Unlike the analysis of
TLG alone, the combined analysis of
V and
SUV led to a tumor classification similar to that obtained from the clinician interpretation.
| ||||||||||||||||||||||||||||||||||||||